SCHEMBL5535221

SCHEMBL5535221

CCCCCCCCCCCCCC[n+]1ccccc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.56
KMT2A Q03164 7/20 0.56
NPC1 O15118 6/20 0.56
RAB9A P51151 6/20 0.56
HTT P42858 6/20 0.56
MEN1 O00255 6/20 0.56
KDM4E B2RXH2 5/20 0.56
NPSR1 Q6W5P4 3/20 0.56
LMNA P02545 3/20 0.56
MAPK1 P28482 3/20 0.56
RAD52 P43351 3/20 0.56
HSP90AA1 P07900 2/20 0.56
RGS12 O14924 1/20 0.56
USP2 O75604 1/20 0.56
THRB P10828 1/20 0.56
MCL1 Q07820 1/20 0.56
POLB P06746 1/20 0.52
ALDH1A1 P00352 4/20 0.49
GAA P10253 4/20 0.49
CYP1A2 P05177 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5532642 1.00 SMN1; SMN2 (0.56) SMN1; SMN2KMT2ANPC1RAB9AHTT
SCHEMBL5522400 1.00 SMN1; SMN2 (0.56) SMN1; SMN2KMT2ANPC1RAB9AHTT
SCHEMBL28010156 1.00 SMN1; SMN2 (0.56) SMN1; SMN2KMT2ANPC1RAB9AHTT
SCHEMBL5519301 1.00 SMN1; SMN2 (0.56) SMN1; SMN2KMT2ANPC1RAB9AHTT
SCHEMBL5513956 1.00 SMN1; SMN2 (0.56) SMN1; SMN2KMT2ANPC1RAB9AHTT
Hydrochloric Acid SCHEMBL28950340 0.98 SMN1; SMN2 (0.54) SMN1; SMN2KMT2ANPC1RAB9AHTT
SCHEMBL27689587 0.92 NPC1 (0.46) SMN1; SMN2KMT2ANPC1RAB9AHTT
Trifluoromethanesulfonic Acid SCHEMBL31435218 0.84 KCNH2 (0.50) SMN1; SMN2KMT2ANPC1RAB9AHTT
Perchlorate SCHEMBL11795106 0.83 NPC1 (0.48) SMN1; SMN2NPC1RAB9APOLBACHE
Hydrochloric Acid SCHEMBL8179702 0.81 SMN1; SMN2 (0.59) SMN1; SMN2KMT2ANPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070042030-A1 Preparation for the application of agents in mini-droplets IDEA AG (DE) 2007-02-22 US disclosed
US-6165500-A Preparation for the application of agents in mini-droplets IDEA AG (DE) 2000-12-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070042030-A1 Preparation for the application of agents in mini-droplets FABP4, NPC1L1, LIPA SMN1; SMN2 4016/4885KMT2A 4875/4885NPC1 53/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.